prednisone has been researched along with Deficiency, Factor II in 16 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Therapy with prednisone was commenced following recurrent severe epistaxis." | 3.68 | Acquired hypoprothrombinaemia and lupus anticoagulant: response to steroid therapy. ( Bird, AR; Hift, RJ; Sarembock, BD, 1991) |
| "A 66-year-old man with the lupus anticoagulant-hypoprothrombinemia syndrome was treated with cyclophosphamide and prednisone to correct a factor II deficiency prior to elective major surgery." | 3.67 | Correction of hypoprothrombinemia by immunosuppressive treatment of the lupus anticoagulant-hypoprothrombinemia syndrome. ( Adams, J; Greenberg, CS; Simel, DL; St Clair, EW, 1987) |
| "The lupus anticoagulant-hypoprothrombinemia syndrome (LA-HPS) - the association of acquired factor II deficiency and lupus anticoagulant - is a rare disease that may cause a predisposition not only to thrombosis but also to severe bleeding." | 1.43 | Lupus anticoagulant-hypoprothrombinemia syndrome presenting with co-existing cerebral venous thrombosis and subdural hemorrhage. ( Bel Feki, N; Ben Ghorbel, I; Houman, MH; Zayet, S, 2016) |
| "Lupus anticoagulant hypoprothrombinemia syndrome (LAHPS) is a rare disorder characterized by a bleeding tendency due to factor II deficiency associated with the presence of lupus anticoagulant (LAC) autoantibodies." | 1.33 | Thromboembolism complicating the treatment of lupus anticoagulant hypoprothrombinemia syndrome. ( Rich, E; Senécal, JL; Vinet, E, 2006) |
| "Antipyrine has been used as a model drug to investigate the effects of liver disease on drug metabolism in man." | 1.25 | Determinants of serum antipyrine half-lives in patients with liver disease. ( Branch, RA; Herbert, CM; Read, AE, 1973) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (62.50) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bel Feki, N | 1 |
| Zayet, S | 1 |
| Ben Ghorbel, I | 1 |
| Houman, MH | 1 |
| Paschal, RD | 1 |
| Neff, AT | 1 |
| KOZINN, PJ | 1 |
| RITZ, ND | 1 |
| MOSS, AH | 1 |
| KAUFMAN, A | 1 |
| Sellami, M | 1 |
| Elloumi, M | 1 |
| Fourati, H | 1 |
| Ayadi, N | 1 |
| Baklouti, S | 1 |
| Vinet, E | 1 |
| Rich, E | 1 |
| Senécal, JL | 1 |
| Edgin, RA | 1 |
| Metz, EN | 1 |
| Fromkes, JJ | 1 |
| Beman, FM | 1 |
| de Larrañaga, G | 1 |
| Forastiero, R | 1 |
| Carreras, LO | 1 |
| Zala, N | 1 |
| Guzman, L | 1 |
| Alonso, B | 1 |
| Lillquist, KB | 1 |
| Dyerberg, J | 1 |
| Krogh-Jensen, M | 1 |
| Hift, RJ | 1 |
| Bird, AR | 1 |
| Sarembock, BD | 1 |
| Elezović, I | 1 |
| Djukanović, R | 1 |
| Rolović, Z | 1 |
| Simel, DL | 1 |
| St Clair, EW | 1 |
| Adams, J | 1 |
| Greenberg, CS | 1 |
| Camoriano, JK | 1 |
| Greipp, PR | 1 |
| Bayer, GK | 1 |
| Bowie, EJ | 1 |
| Levin, M | 1 |
| Chokas, W | 1 |
| Quitt, M | 1 |
| Aghai, E | 1 |
| David, M | 1 |
| Kohan, R | 1 |
| Ben Ari, Y | 1 |
| Froom, P | 1 |
| Branch, RA | 1 |
| Herbert, CM | 1 |
| Read, AE | 1 |
| Corrigan, JJ | 1 |
| Patterson, JH | 1 |
| May, NE | 1 |
1 review available for prednisone and Deficiency, Factor II
| Article | Year |
|---|---|
Resolution of Hypoprothrombinemia-Lupus Anticoagulant Syndrome (HLAS) after multidrug therapy with rituximab: a case report and review of the literature.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antiphospholipid Syndrome; Drug Therapy, Combination; | 2013 |
15 other studies available for prednisone and Deficiency, Factor II
| Article | Year |
|---|---|
Lupus anticoagulant-hypoprothrombinemia syndrome presenting with co-existing cerebral venous thrombosis and subdural hemorrhage.
Topics: Adult; Antiphospholipid Syndrome; Cerebral Veins; Female; Hematoma, Subdural; Humans; Hypoprothrombi | 2016 |
MASSIVE HEMORRHAGE--SCALPS OF NEWBORN INFANTS.
Topics: Anemia; Exchange Transfusion, Whole Blood; Factor VII Deficiency; Factor VIII; Hemophilia B; Hemorrh | 1964 |
[Combined hypoprothrombinemia-antiphospholipid syndrome in a patient suffering from lupus].
Topics: Adult; Anti-Inflammatory Agents; Antiphospholipid Syndrome; Glucocorticoids; Humans; Hypoprothrombin | 2004 |
Thromboembolism complicating the treatment of lupus anticoagulant hypoprothrombinemia syndrome.
Topics: Adrenal Cortex Hormones; Antiphospholipid Syndrome; Azathioprine; Central Nervous System Diseases; C | 2006 |
Acquired factor X deficiency with associated defects in platelet aggregation. A response to corticosteroid therapy.
Topics: Aged; Bleeding Time; Factor X Deficiency; Female; Humans; Hypoprothrombinemias; Partial Thromboplast | 1980 |
Acquired hypoprothrombinemia related to high titres of antiprotein-phospholipid antibodies.
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Antibody Specificity; Autoimmune D | 1999 |
The absence of factor II in a child with systemic lupus erythematosus.
Topics: Child; Humans; Hypoprothrombinemias; Lupus Erythematosus, Systemic; Male; Prednisone | 1978 |
Acquired hypoprothrombinaemia and lupus anticoagulant: response to steroid therapy.
Topics: Adult; Blood Coagulation Factors; Epistaxis; Humans; Hypoprothrombinemias; Lupus Coagulation Inhibit | 1991 |
Successful treatment of hemorrhagic syndrome due to an acquired, combined deficiency of factors VII and X in a patient with multiple myeloma and amyloidosis.
Topics: Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Factor VII Deficiency | 1989 |
Correction of hypoprothrombinemia by immunosuppressive treatment of the lupus anticoagulant-hypoprothrombinemia syndrome.
Topics: Aged; Autoantibodies; Blood Coagulation Factors; Cyclophosphamide; Hemorrhagic Disorders; Humans; Hy | 1987 |
Resolution of acquired factor X deficiency and amyloidosis with melphalan and prednisone therapy.
Topics: Aged; Amyloidosis; Factor X Deficiency; Humans; Hypoprothrombinemias; Liver; Male; Melphalan; Predni | 1987 |
Acquired factor X deficiency and amyloidosis treated with melphalan and prednisone.
Topics: Amyloidosis; Drug Therapy, Combination; Factor X Deficiency; Humans; Hypoprothrombinemias; Melphalan | 1987 |
Acquired factor X and antithrombin III deficiency in a patient with primary amyloidosis and nephrotic syndrome.
Topics: Amyloidosis; Antithrombin III Deficiency; Biopsy; Blood Coagulation Tests; Colchicine; Factor X Defi | 1985 |
Determinants of serum antipyrine half-lives in patients with liver disease.
Topics: Adult; Alkaline Phosphatase; Antipyrine; Aspartate Aminotransferases; Bilirubin; Half-Life; Hepatiti | 1973 |
Incoagulability of the blood in systemic lupus erythematosus. A case due to hypoprothrombinemia and a circulating anticoagulant.
Topics: Anticoagulants; Blood Coagulation Disorders; Blood Coagulation Factors; Child; Female; Hematuria; Hu | 1970 |